The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Capitalism and greed gave Britain its vaccine success, PM Johnson says

Tue, 23rd Mar 2021 21:51

* Johnson tries to row back from gaffe on greed

* Praises capitalism in vaccine lead

* UK state money developed the Oxford vaccine

* Communist China moved fast to develop a vaccine
(Adds context on Oxford vaccine)

By Costas Pitas

LONDON, March 24 (Reuters) - Capitalism and greed gave
Britain its success in vaccinating its population, Prime
Minister Boris Johnson told lawmakers in a closed meeting, a
remark that could rile up Brussels at a time when Britain faces
an EU threat to block vaccine imports.

"The reason we have the vaccine success is because of
capitalism, because of greed my friends," The Sun newspaper
quoted Johnson as telling Conservative lawmakers on a Zoom
meeting on Tuesday evening.

Johnson then tried to row back and said: "Actually I regret
saying it" and asked lawmakers repeatedly to "forget I said
that".

Britain has so far mounted the fastest COVID-19 vaccine
programme of any big country. But it now finds its programme
threatened by the EU, which has been far slower in rolling out
vaccines and faces a third wave of infections.

The European Commission is expected on Wednesday to extend
powers to block exports, a move that could hit supply of doses
bound for Britain. Johnson's remarks come after a week in which
British ministers have tried to calm the row.

Downing Street declined to comment on Johnson's remarks when
contacted by Reuters, but unidentified sources gave the BBC a
bizarre array of explanations.

The greed comment, according to the BBC's political editor
Laura Kuenssberg, was apparently a joke about one of his cabinet
colleagues, Chief Whip Mark Spencer, who was gobbling a cheese
and pickle sandwich while the prime minister spoke.

Johnson, Home Secretary Priti Patel said, was talking about
the success of pharmaceutical companies in developing a vaccine
shot in record time.

"Clearly the prime minister was actually referring to the
work that has taken place with pharmaceutical companies and how
we have led the way really in this vaccine development," said
Patel, who was not in the meeting.

Britain was one of several countries that developed a
COVID-19 vaccine shot in record time: the shot developed by
Oxford University and AstraZeneca was approved for use
on Dec. 30 by the British medicines regulator.

The British government helped fund the research, and
AstraZeneca has promised to market it on a not-for-profit basis.

Other vaccines around the world have been developed with
state funding, from Communist China and former communist Russia
to the capitalist United States.
(Reporting by Costas Pitas and Guy Faulconbridge; Editing by
Steve Orlofsky, Rosalba O'Brien, Kate Holton and Peter Graff)

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.